Better performance of PIVKA-II for detecting hepatocellular carcinoma in patients with chronic liver disease with normal total bilirubin

BACKGROUND: Serum protein induced by vitamin K absence or antagonist-II (PIVKA-II) is a promising biomarker for hepatocellular carcinoma (HCC) surveillance. AIM: To identify the contributing factors related to the abnormal elevation of PIVKA-II level and assess their potential influence on the perfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xiang-Jun, Wen, Zhu-Mei, Huang, Xiao-Ming, Feng, Hui-Juan, Lin, Shan-Shan, Liu, Yan-Na, Li, Sheng-Cong, Zhang, Yu, Peng, Wen-Guang, Yang, Jia-Rui, Zheng, Zhe-Yu, Zhang, Lei, Zhang, Da-Wei, Lu, Feng-Min, Liu, Li-Juan, Pan, Wei-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011960/
https://www.ncbi.nlm.nih.gov/pubmed/36925461
http://dx.doi.org/10.3748/wjg.v29.i8.1359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011960/
https://www.ncbi.nlm.nih.gov/pubmed/36925461
http://dx.doi.org/10.3748/wjg.v29.i8.1359

Ejemplares similares